GHCM
DPLO

Glen Harbor Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Glen Harbor Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11,764
Closed -$68K – 1345
2019
Q1 		$68K Hold
11,764
– – ﹤0.01% 1203
2018
Q4 		$158K Buy
11,764
+1,904
+19% +$32.1K ﹤0.01% 1011
2018
Q3 		$191K Buy
9,860
+3,366
+52% +$71.7K ﹤0.01% 1069
2018
Q2 		$166K Buy
6,494
+68
+1% +$1.59K ﹤0.01% 1027
2018
Q1 		$129K Buy
+6,426
New +$150K ﹤0.01% 1096
2017
Q1 		– Sell
-1,700
Closed -$22K – 1288
2016
Q4 		$22K Buy
+1,700
New +$31.7K ﹤0.01% 1195

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $8.93B AUM 25.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Glen Harbor Capital Management's DPLO Position: Q2 2019 in Review

Glen Harbor Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2019, closing a stake of 11,764 shares — an estimated $68K sold.

Glen Harbor Capital Management first reported a position in DPLO in Q4 2016 and held it in 6 quarters. The position peaked at $191K in Q3 2018. 131 funds tracked by Wall St. Rank hold DPLO as of Q2 2019.

  • Glen Harbor Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2019 after selling out during the quarter.
  • Glen Harbor Capital Management sold 11,764 DIPLOMAT PHARMACY, INC. shares in Q2 2019, an estimated $68K.
  • Glen Harbor Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2016 and held it in 6 quarters.
  • Glen Harbor Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $191K in Q3 2018.
  • 131 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2019.

Based on Glen Harbor Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.